Abbott, AbbVie win dismissal of claims over Humira, AndroGel
September 25, 2014 at 19:56 PM EDT
Sept 25 (Reuters) - A federal judge in Chicago dismissed racketeering claims in a lawsuit accusing Abbott Laboratories and AbbVie Inc of causing health plans to pay unnecessarily for the latter's blockbuster Humira arthritis drug and AndroGel testosterone drug instead of cheaper generics.